GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (LTS:0RBP) » Definitions » Total Inventories

Kiadis Pharma NV (LTS:0RBP) Total Inventories : €0.00 Mil (As of Dec. 2020)


View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Total Inventories?

Kiadis Pharma NV's total inventories for the quarter that ended in Dec. 2020 was €0.00 Mil. Kiadis Pharma NV's average total inventories from the quarter that ended in Jun. 2020 to the quarter that ended in Dec. 2020 was €0.00 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Kiadis Pharma NV's Net-Net Working Capital per share for the quarter that ended in Dec. 2020 was €-2.03.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Kiadis Pharma NV's Inventory-to-Revenue for the quarter that ended in Dec. 2020 was 0.00.


Kiadis Pharma NV Total Inventories Historical Data

The historical data trend for Kiadis Pharma NV's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Total Inventories Chart

Kiadis Pharma NV Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Total Inventories
Get a 7-Day Free Trial Premium Member Only - - - - -

Kiadis Pharma NV Semi-Annual Data
Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kiadis Pharma NV Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Kiadis Pharma NV  (LTS:0RBP) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Kiadis Pharma NV's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2020 is

Net-Net Working Capital Per Share (Q: Dec. 2020 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(13.658+0.75 * 0+0.5 * 0-95.681
-0-0)/40.3085
=-2.03

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Kiadis Pharma NV's Days Inventory for the six months ended in Dec. 2020 is calculated as:

Days Inventory=Average Total Inventories (Q: Dec. 2020 )/Cost of Goods Sold (Q: Dec. 2020 )*Days in Period
=0/0*365 / 2
=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Kiadis Pharma NV's Inventory Turnover for the quarter that ended in Dec. 2020 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Dec. 2020 ) / Average Total Inventories (Q: Dec. 2020 )
=0 / 0
=N/A

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Kiadis Pharma NV's Inventory to Revenue for the quarter that ended in Dec. 2020 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Dec. 2020 ) / Revenue (Q: Dec. 2020 )
=0 / 17.5
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Kiadis Pharma NV Total Inventories Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Kiadis Pharma NV (LTS:0RBP) Business Description

Traded in Other Exchanges
N/A
Address
Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP
Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (LTS:0RBP) Headlines

No Headlines